In contrast, treatment with cetuximab did not suppress tumor growth (Fig. 6a) or affect involucrin expression (Fig. 6b) in TE-8 (mesenchymal-like ESCC cells)-derived xenograft tumors. This evidence concerns the gene IVL and esophageal squamous cell carcinoma.